When, how, why and whom for there will be an "after" Covid-19?

被引:0
作者
Tognoni, Gianni [1 ]
机构
[1] Fdn IRCSS Ca Granda Osped Maggiore Policlin, Milan, Italy
关键词
Covid-19; clinical trials; outcomes;
D O I
10.1702/3454.34432
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The announced, but unpredicted, radical and global experience of the Covid-19 pandemia has revealed the degree of ignorance, fragmentation, inadequacy of the national and international knowledge and strategies of intervention and, even more substantially, of coordination across all the critical areas of prevention and care. The importance of the nursing component of the organisation and of the technical and cultural aspects of health care delivery and accessibility has been underlined as a protagonist of the resistance and resilience during the worst period of the emergency, and should be specifically involved in this renewal, where a profound modification of the interactions, hierarchies, roles of various professions is required. A long term, widespread, flexible experimentation of country specific and international solutions must be envisaged and timely activated. The 'grammar' and the major concrete characteristics of the methodology which could be usefully adopted to guarantee the feasibility and effectiveness of this 'systemic' experimentation are proposed and exemplified.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [31] Partisanship and the Pandemic: How and Why Americans Followed Party Cues on COVID-19
    Mehlhaff, Isaac D.
    Tarillo, Matias C.
    Vanegas, Ayelen
    Hetherington, Marc J.
    JOURNAL OF HEALTH POLITICS POLICY AND LAW, 2024, 49 (03) : 351 - 374
  • [32] Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
    Saptarshi Sinha
    Chanakya Nath Kundu
    Medical Oncology, 2021, 38
  • [33] How Indian agriculture should change after COVID-19
    Anjani Kumar
    Arabinda K. Padhee
    Shalander Kumar
    Food Security, 2020, 12 : 837 - 840
  • [34] How Indian agriculture should change after COVID-19
    Kumar, Anjani
    Padhee, Arabinda K.
    Kumar, Shalander
    FOOD SECURITY, 2020, 12 (04) : 837 - 840
  • [35] Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
    Sinha, Saptarshi
    Kundu, Chanakya Nath
    MEDICAL ONCOLOGY, 2021, 38 (09)
  • [36] The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
    Khong, Ka-Wa
    Zhang, Ruiqi
    Hung, Ivan Fan-Ngai
    VACCINES, 2022, 10 (11)
  • [37] Understanding for whom, how and why Sydney Local Health District's Integrated Response was Effective in Addressing COVID-19: A Critical Realist Qualitative Study
    Liu, Hueiming
    Liu, Darith
    Moore, Corey
    Parcsi, Lisa
    Mukumbang, Ferdinand
    De Souza, Denise
    Shaw, Miranda
    Blunden, Lou-Anne
    Anderson, Teresa
    Eastwood, John
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2022, 22 (01):
  • [38] When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality?
    Lockhart, Sam M.
    O'Rahilly, Stephen
    MED, 2020, 1 (01): : 33 - 42
  • [39] Whether, when and how to extend unemployment benefits: Theory and application to COVID-19
    Mitman, Kurt
    Rabinovich, Stanislav
    JOURNAL OF PUBLIC ECONOMICS, 2021, 200
  • [40] What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review
    Liu, Kunmeng
    Zhang, Xiaoming
    Hu, Yuanjia
    Chen, Weijie
    Kong, Xiangjun
    Yao, Peifen
    Cong, Jinyu
    Zuo, Huali
    Wang, Jian
    Li, Xiang
    Wei, Benzheng
    FRONTIERS IN MEDICINE, 2022, 9